• CMP Pharma Announces FDA Approval of CaroSpir americanpharmaceuticalreview
    August 08, 2017
    CMP and FDA has granted final approval of the company’s New Drug Application (NDA) for CaroSpir.The dosing inconsistencies of compounded liquids have long been a persistent challenge for physicians.
PharmaSources Customer Service